bioMérieux switches to Teklynx Central software

France-based global biotechnology company bioMérieux has switched to Teklynx Central software package to centralize labeling for 15,000 its products and increase accuracy and regulatory compliance.

bioMérieux switches to Teklynx Central software to centralize labeling for 15,000 its products and increase accuracy and regulatory compliance.

Headquartered in France, bioMérieux is a multinational biotechnology company driven to improve public health around the world. With over 15,000 products, access to labels by over 400 employees, and more than 300 products, shipping, and inventory labels, bioMérieux, along with partner Eticoncept sought out Teklynx to offer a standardized option for its entire labeling environment.

‘Our current labeling technology didn’t allow us to be centralized within our environment, that was a necessity when finding a new solution for bioMérieux,’ said Jérôme Foltz, IS manufacturing and MDM domain manager at bioMérieux.

Implementing the software package allowed the bioMérieux team to increase the accuracy and compliance of its labels to 100 percent. ‘Teklynx Central has improved labeling efficiency and accuracy of our entire labeling process. It is a solution that allows for seamless labeling operations as well as providing the support we need along the way,’ added Foltz.

By standardizing and centralizing its labeling process, bioMérieux has gained the ability to create high quality label designs, improve labeling security and tracking, operate more efficiently with meeting CFR regulations. The company has also increased labeling and print speeds and significantly saved time and reduced errors by centrally managing over 300 labels in an organized fashion. The software package enables bioMériuex to provide accurate, GS1 and UDI compliant labels, integrated seamlessly with its current business system, SAP ECC.

‘We take great pride in knowing that our enterprise-level, integrated label management system improves the accuracy and compliance of labels for bioMérieux, positioning them to keep driving growth within the medical device industry around the world now and into the future,’ commented Thierry Mauger, president of Teklynx.